Literature DB >> 19488006

Prevalence of gout and hyperuricemia in Taiwan: a hospital-based, cross-sectional study.

Shih-Wei Lai, Chiu-Shong Liu, Tsann Lin, Cheng-Chieh Lin, Hsueh-Chou Lai, Kuan-Fu Liao.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19488006     DOI: 10.1097/SMJ.0b013e3181a8cab9

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


× No keyword cloud information.
  6 in total

1.  Mortality due to coronary heart disease and kidney disease among middle-aged and elderly men and women with gout in the Singapore Chinese Health Study.

Authors:  Gim Gee Teng; Li-Wei Ang; Kenneth G Saag; Mimi C Yu; Jian-Min Yuan; Woon-Puay Koh
Journal:  Ann Rheum Dis       Date:  2011-12-15       Impact factor: 19.103

2.  Comparison of Benzbromarone and Allopurinol on Primary Prevention of the First Gout Flare in Asymptomatic Hyperuricemia.

Authors:  Shih-Wei Lai; Kuan-Fu Liao; Yu-Hung Kuo; Chiu-Shong Liu; Bing-Fang Hwang
Journal:  J Pers Med       Date:  2022-04-27

3.  Allopurinol use and the risk of dementia: A meta-analysis of case-control studies.

Authors:  Shih-Wei Lai; Bing-Fang Hwang; Yu-Hung Kuo; Chiu-Shong Liu; Kuan-Fu Liao
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

4.  Epidemiology and management of gout in Taiwan: a nationwide population study.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Lai-Chu See; Kuang-Hui Yu; Shue-Fen Luo; Weiya Zhang; Michael Doherty
Journal:  Arthritis Res Ther       Date:  2015-01-23       Impact factor: 5.156

5.  Hyperuricemia might be an early manifestation of undiagnosed adult leukemia in a population-based cohort study.

Authors:  Shih-Wei Lai; Cheng-Li Lin; Kuan-Fu Liao
Journal:  Biomedicine (Taipei)       Date:  2020-03-28

6.  Allopurinol use associated with increased risk of acute myocardial infarction in older people in a case-control study.

Authors:  Kuan-Fu Liao; Cheng-Li Lin; Shih-Wei Lai
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2019-09-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.